Symptomatic Brain Radiation Necrosis in an Anaplastic Lymphoma Kinase (ALK)-Positive Non-small Cell Lung Cancer (NSCLC) Patient After Fractionated Stereotactic Radiotherapy While on Alectinib

Anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) has a higher incidence of brain metastasis. Despite having a favorable prognosis and relatively long survival with second-generation ALK tyrosine kinase inhibitors (TKI), patients can have substantial morbidity, negatively...

Descripción completa

Detalles Bibliográficos
Autores principales: BalajiSubramanian, Sitaraman, Al Hajri, Thuraya, Satyapal, Namrata, Laiq, Simin, Al Hajri, Zahra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Radiation Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082649/
https://www.ncbi.nlm.nih.gov/pubmed/37038567
http://dx.doi.org/10.7759/cureus.35952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082649/
https://www.ncbi.nlm.nih.gov/pubmed/37038567
http://dx.doi.org/10.7759/cureus.35952

Ejemplares similares